Excretion of ofloxacin into saliva in rats with renal failure

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 31-36

  Ding, Guohua ^a,b   Naora, Kohji ^a   Nagasako, Sadao ^a   Hirano, Hidenari ^a   Iwamoto, Kikuo ^a  

^a SHIMANE UNIVERSITY HOSPITAL   (Japan)

^b Heilongjiang Provincial 2nd Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG SALIVA LEVEL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; NONHUMAN; PAROTID GLAND; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RAT; SUBMANDIBULAR GLAND;

ANIMALS; ANTI-INFECTIVE AGENTS; HYDROGEN-ION CONCENTRATION; KIDNEY FAILURE; MALE; NEPHRECTOMY; OFLOXACIN; RATS; RATS, WISTAR; SALIVA;

EID: 0032461362     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Control 19:716-723.
2. Allen MA, Wrenn JM, Putney JW and Borzelleca JF (1976) A study of the mechanism of transport of diphenylhydantoin in the rat submaxillary gland in vitro. J Pharmacol Exp Ther 197:408-413.
3. Basseches PJ and DiGregorio GJ (1982) Excretion of procainamide into bile and saliva in rats with chronic renal failure. Arch Int Pharmacodyn 257:180-187.
4. Dawes CP, Kendall MJ and John VA (1978) Comparison of plasma and saliva levels of metoprolol and oxprenolol. Br J Clin Pharmacol 5:217-221.
5. Drobitch RK and Svensson CK (1992) Therapeutic drug monitoring in saliva: An update. Clin Pharmacokinet 23:365-379.
6. Fillastre JP, Leroy A and Humbert G (1987) Ofloxacin pharmacokinetics in renal failure. Antimicrob Agents Chemother 31:156-160.
7. Furet YX, Deshusses J and Pechère J-C (1992) Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 36:2506-2511.
8. Giacomini KM, Roberts SM and Levy G (1981) Evaluation of methods for producing renal dysfunction in rats. J Pharm Sci 70:117-121.
9. Haeckel R and Hänecke P (1996) Application of saliva for drug monitoring: An in vivo model for transmembrane transport. Eur J Clin Chem Clin Biochem 34:171-191.
10. Ichikawa N, Naora K, Hayashibara M, Katagiri Y and Iwamoto K (1992) Effect of fenbufen on the entry of new quinolones, norfloxacin and ofloxacin, into the central nervous system in rats. J Pharm Pharmacol 44:915-920.
11. Ichihara N, Tachizawa H, Tsumura M, Une T and Sato K (1984) Phase I study on DL-8280. Chemotherapy (Tokyo) 32:(S-1):118-149.
12. Katagiri Y, Naora K, Ichikawa N, Hayashibara M and Iwamoto K (1988) Simultaneous determination of ofloxacin, fenbufen and felbinac in rat plasma by high-performance liquid chromatography. J Chromatogr 431:135-142.
13. Kinashi M, Ohbayashi S and Ohbayashi M (1989) Detection of amyloid-like fibrils using labial salivary gland biopsy in patients with nondialysis renal insufficiency. Am J Nephrol 9:435-437.
14. Koizumi F, Ohnishi A, Takemura H, Okubo S, Kagami T and Tanaka T (1994) Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections. Antimicrob Agents Chemother 38:1140-1143.
15. Okano T, Maegawa H, Inui K-I and Hori R (1990) Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes. J Pharmacol Exp Ther 255:1033-1037.
16. Ooie T, Suzuki H, Terasaki T and Sugiyama Y (1996a) Characterization of the transport properties of a quinolone antibiotic, fleroxacin, in rat choroid plexus. Pharm Res 13:523-527.
17. Ooie T, Suzuki H, Terasaki T and Sugiyama Y (1996b) Kinetics of quinolone antibiotics in rats: Efflux from cerebrospinal fluid to the circulation. Pharm Res 13:1065-1068.
18. Ross DL and Riley CM (1990) Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharm 63:237-250.
19. Shiiki K (1989) Penetration of new quinolones into saliva. Chemotherapy (Tokyo) 37:604-609.
20. Sörgel F, Jaehde U, Naber K and Stephan U (1989) Pharmacokinetic disposition of quinolones in human body fluids and tissues. Clin Pharmacokinet 16(Suppl. 1):5-24.
21. Takagi K, Hasegawa T, Yamaki K, Suzuki K and Nabeshima T (1992) Secretion of ofloxacin into saliva in patients with respiratory tract infection. Int J Clin Pharmacol Ther Toxicol 30:46-50.
22. Tamarin A and Sreebny LM (1965) The rat submaxillary salivary gland: A correlative study by light and electron microscopy. J Morphol 117:295-352.
23. Tsubakihara Y, Hayashi T, Shoji T, Kitamura E, Okada N and Nakanishi I (1994) Pharmacokinetic study of ofloxacin using saliva concentration in chronic renal failure. Nippon Jinzo Gakkai Shi 36:246-249.
24. Warlich R, Korting HC, Schäfer-Korting M and Mutschler E (1990) Multiple-dose pharmacokinetics of ofloxacin in serum, saliva and skin blister fluid of healthy volunteers. Antimicrob Agents Chemother 34:78-81.
25. Watanabe J, Koyama I, Iwamoto K and Ozeki S (1987) Mandibular and parotid salivary excretion of procainamide and N-acetylprocainamide after intravenous administration of procainamide to rats. J Pharm Pharmacol 39:912-916.
26. Watanabe J, Nakase Y, Urasaki Y, Hayashi Y, Iwamoto K and Ozeki S (1981) Protein binding effects on salivary excretion of phenobarbital in dogs. J Pharmacobiodyn 4:968-977.
27. Watanabe J, Setoyama T, Iwamoto K, Hayashi Y and Ozeki S (1985) Mandibular and parotid salivary levels of indomethacin following intravenous administration to rabbits. Pharm Res 2:185-187.
28. Wise R and Lockley MR (1988) The pharmacokinetics of ofloxacin and a review of its tissue penetration. J Antimicrob Chemother 22:(Suppl C):59-64.
29. Wolfson JS and Hooper DC (1985) The fluoroquinolones: Structures, mechanisms of action and resistance and spectra of activity in vitro. Antimicrob Agents Chemother 28:581-586.
30. Wolfson JS and Hooper DC (1989) Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 2:378-424.
31. Yamaki K, Taki F, Suzuki R, Takagi K and Satake T (1992) Therapeutic drug monitoring by determining salivary concentration of ofloxacin: Single- and multiple-dose studies of patients with chronic respiratory tract infections. Chemotherapy (Tokyo) 40:28-32.